University Lille Nord de France; INSERM, U1011; UDSL; Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP245, 59019 Lille, France.
Curr Diab Rep. 2011 Jun;11(3):160-6. doi: 10.1007/s11892-011-0187-x.
Type 2 diabetes (T2D) is a growing health problem worldwide, but the currently available strategies for therapy and prevention are insufficient. Recent observations indicate that bile acid homeostasis is altered in T2D. Bile acids are metabolic regulators that act as signaling molecules through receptor-dependent and -independent pathways. The most prominent signaling molecules mediating bile acid signaling are the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor TGR5. Both are implicated in the regulation of lipid, glucose, and energy metabolism. Dysregulation of these pathways might contribute to the development of T2D and associated complications. Interestingly, data from studies with bile acids or bile acid sequestrants indicate that the manipulation of bile acid homeostasis might be an attractive approach for T2D therapy. In this review, we summarize the mechanisms of bile acid-mediated metabolic control that might be relevant in the pathogenesis of T2D.
2 型糖尿病(T2D)是全球日益严重的健康问题,但目前用于治疗和预防的策略还不够。最近的观察表明,T2D 患者的胆汁酸动态平衡发生改变。胆汁酸是代谢调节剂,通过受体依赖性和非依赖性途径作为信号分子发挥作用。介导胆汁酸信号的最突出的信号分子是核受体法尼醇 X 受体(FXR)和膜受体 TGR5。两者都参与脂质、葡萄糖和能量代谢的调节。这些途径的失调可能导致 T2D 及其相关并发症的发生。有趣的是,来自胆汁酸或胆汁酸螯合剂研究的数据表明,对胆汁酸动态平衡的干预可能是治疗 T2D 的一种有吸引力的方法。在这篇综述中,我们总结了胆汁酸介导的代谢控制机制,这些机制可能与 T2D 的发病机制有关。